Speech-Language Pathologists in Wyoming, MI Accepting Medicare

26 Speech-Language Pathologists found. Showing 21 - 26

Hannah Elizabeth Boersma Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5900 Byron Center Ave Sw, Wyoming, MI 49519 Phone: 616-252-7482

Samantha Mcdaniel, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5900 Byron Center Ave Sw, Wyoming, MI 49519 Phone: 616-252-7199

Mrs. Marissa Lauren Bergsma, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2786 56th St Sw, Wyoming, MI 49418 Phone: 616-261-3960

Aimee Rose Heiniger, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2250 28th St Sw Ste 2, Wyoming, MI 49519 Phone: 616-379-9887

Grace Smith, M.A., CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5722 Metro Way Sw Ste B, Wyoming, MI 49519 Phone: 616-840-7529    Fax: 616-840-9693

Mrs. Cathy Welsh Olson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5900 Byron Center Ave Sw, Wyoming, MI 49519 Phone: 616-252-7482    Fax: 616-252-6970

News Archive

Helicos Biosciences to raise $10 million through private placement

Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets, today announced that it has entered into a definitive agreement with certain new and existing investors, including Atlas Ventures, Flagship Ventures, Highland Capital Partners, Versant Ventures (the "Existing Investors") and Ron Lowy, the Company's chief executive officer, to raise approximately $10 million in gross proceeds in a private placement through the sale of shares of its common stock and warrants.

Researchers discover new gene mutations which cause devastating mitochondrial disorders

Researchers have identified a novel disease gene in which mutations cause rare but devastating genetic diseases known as mitochondrial disorders.

Aggressive public health efforts to control hypertension may help preserve cognitive abilities as well as cardiovascular health

Not only does high blood pressure adversely affect mental functioning, but the correlation appears to be stronger among African-Americans than among whites, researchers report in the current issue of Psychosomatic Medicine.

Mylan launches Tolterodine Tartrate ER Capsules, 2 mg and 4 mg

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)